Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psoriasis
Pharma
Dermavant CEO draws Botox comparison to instill Vtama confidence
Dermavant CEO Todd Zavodnick isn’t worried about the disappointing uptake of Vtama, saying it will flourish when it is approved for atopic dermatitis.
Kevin Dunleavy
Nov 28, 2023 4:10pm
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
Total spend on leading drug ads in October jumps to $221M
Nov 7, 2023 9:15am
Novartis' Cosentyx clinches FDA nod in lesser-known skin disease
Nov 1, 2023 9:45am
BMS' campaign explores skin color's role in psoriasis experience
Oct 31, 2023 7:50am
Almirall drills home message about psoriasis' mental health toll
Oct 30, 2023 10:18am
